BioSpace News Archive

Business

NuVasive, Inc. Reports Third Quarter 2007 Revenue of $38.5 Million

October 25, 2007
·
8 min read
Drug Development

Exelixis, Inc. Interim Phase 2 Data for Exelixis’ XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer Tumor Shrinkage Observed in Nearly 80% of Patients

October 25, 2007
·
7 min read
Business

Bruker BioSciences Corporation to Release Third Quarter 2007 Financial Results on October 29, 2007

October 25, 2007
·
1 min read
Business

Diomed Holdings, Inc. Announces Third Quarter Results

October 25, 2007
·
1 min read
FDA

KV Pharmaceutical Company Gets FDA OK for Morphine ER 100 mg, 200 mg Tablets

October 25, 2007
·
4 min read
Drug Development

BiPar Sciences, Inc. Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor

October 25, 2007
·
2 min read
Business

Inhibitex, Inc. to Host Conference Call to Report Third Quarter 2007 Financial Results on November 9, 2007

October 25, 2007
·
1 min read
Drug Development

Sirion Therapeutics Announces Positive Phase III Results for Difluprednate

October 25, 2007
·
5 min read
Drug Development

Pharmion Corporation and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference

October 25, 2007
·
7 min read
BioMidwest

BioCrossroadsLINX Initiative Advances Indiana’s Drug Development Resources and Facilitates Connections with the Biotech and Pharmaceutical Industry

October 25, 2007
·
1 min read